Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Urology. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

Published in Urology

Journal Scan / Research · October 19, 2022

Predicting the Optimal Number of MRI-Targeted Biopsy Cores Required for Accurate Diagnosis in Patients With Possible Prostate Cancer

Prostate Cancer and Prostatic Diseases


Additional Info

Disclosure statements are available on the authors' profiles:

Prostate Cancer and Prostatic Diseases
MRI-targeted biopsy cores from prostate index lesions: assessment and prediction of the number needed
Prostate Cancer Prostatic Dis. 2022 Oct 08;[EPub Ahead of Print], NL Beetz, F Dräger, CA Hamm, S Shnayien, MM Rudolph, K Froböse, S Elezkurtaj, M Haas, P Asbach, B Hamm, S Mahjoub, F Konietschke, M Wechsung, F Balzer, H Cash, S Hofbauer, T Penzkofer

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading